NOVAVAX INC Inventory, Finished Goods, Gross
NOVAVAX INC (NVAX) had Inventory, Finished Goods, Gross of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryFinishedGoods · last filed 2026-08-06
- 2026-06-30: Inventory, Finished Goods, Gross $0.00.
- 2026-03-31: Inventory, Finished Goods, Gross $0.00.
- 2025-12-31: Inventory, Finished Goods, Gross $1.34M.
- 2025-09-30: Inventory, Finished Goods, Gross $4.44M.
| Period end | Inventory, Finished Goods, Gross |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.34M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $4.44M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 |
| 2025-03-31 | $105.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.76M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.63M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $179.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.50M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $27.69M 10-K · filed 2025-02-27 |
| 2023-09-30 | $48.80M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 |
| 2023-03-31 | $8.76M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.36M 10-K · filed 2024-02-28 |
| 2022-09-30 | $31.84M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $129.47M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $5.88M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |